19 October 2026

strategyland.uk

Rosebank Industries PLC (ROSE)

Rank #67 of 280 - Financials - UK Equities

Home/Stocks/Financials

Rosebank Industries PLC

ROSE.L·Financials·Market Cap £3.1b

Rank #67 of 280

Quantitative Model · 280 Stocks Analysed

£3.10

-11.43% YTD

52W: £2.94 - £3.95

Factor Analysis Summary

Editorial assessment generated from Rosebank Industries PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, Rosebank Industries PLC (ROSE.L) currently holds an overall rank of #67 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Its primary strength lies in asset efficiency, where it demonstrates highly efficient capital deployment, converting assets into revenue and returns effectively.

Areas requiring attention include market trading, where low relative volume or adverse volatility patterns may deter momentum-oriented investors, as well as liquidity, where thin trading volumes could increase transaction costs and slippage.

Within the Financials sector, Rosebank Industries PLC sits at composite rank #67, trailing the Financials peer average (rank 8). It ranks behind all 6 tracked Financials peers in our model.

Ranking in the top quartile overall, Rosebank Industries PLC offers a favourable balance of fundamentals, though investors should weigh its asset efficiency advantage against market trading — its relatively weakest factor.

Strongest Factors

Asset Efficiency — Rank 1/280 (top quartile)
Profitability — Rank 139/280 (middle of the pack)
Technical — Rank 153/280 (middle of the pack)

Weakest Factors

Market Trading — Rank 262/280 (below average)
Liquidity — Rank 240/280 (below average)

Score Analysis

Rosebank Industries PLC is ranked #67 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

177/280

Average Score

Liquidity

Weak240/280

Valuation

Weak224/280

Profitability

Fair139/280

Solvency

Weak222/280

Asset Efficiency

Excellent1/280

Mkt Trading

Weak262/280

Technical

Fair153/280

1. Liquidity

Score: 240/280

How liquid is ROSE and can it meet its short-term obligations?

0/6

liquidity criteria met

Metric

Sector Range

Value

Rank

–

Quick Ratio

N/A

1.20xRank 46/280

Range: N/ARank 46/280

–

Current Ratio

N/A

1.76xRank 94/280

Range: N/ARank 94/280

–

TTM Operating Cash Flow

N/A

-0.18xRank 231/280

Range: N/ARank 231/280

–

Liquidity Coverage Ratio

100-150

N/A

Range: 100-150

–

Intangible Asset Ratio

10 - 30

N/ARank 193/280

Range: 10 - 30Rank 193/280

–

Cash-to-Debt Ratio

N/A

0.06xRank 219/280

Range: N/ARank 219/280

Key Liquidity Metrics

Quick Ratio

1.20x

Sector: N/A

Current Ratio

1.76x

Sector: N/A

Overall Liquidity Rank

Rank within universe#240/280

Best (1)Worst (280)

2. Valuation

Score: 224/280

Is ROSE undervalued compared to its peers and fair value metrics?

2/7

valuation criteria met

Metric

Sector Range

Value

Rank

✓

FY27e P/E

8x - 18x

14.4xRank 153/280

Range: 8x - 18xRank 153/280

✗

FY26e P/E

8x - 18x

18.2xRank 171/280

Range: 8x - 18xRank 171/280

✗

FY27e Net Div Yld (%)

3.0 - 8.0

2.88%Rank 140/280

Range: 3.0 - 8.0Rank 140/280

–

Div Payout Ratio

30 - 55

N/ARank 25/280

Range: 30 - 55Rank 25/280

–

Current EV/EBITDA

N/A

30.7xRank 262/280

Range: N/ARank 262/280

–

Current P/TBV

0.8x - 2.0x

N/A

Range: 0.8x - 2.0x

✓

Current P/B

0.8x - 2.0x

1.22xRank 120/280

Range: 0.8x - 2.0xRank 120/280

Key Valuation Metrics

TTM P/E

Price-to-Earnings

N/A

FY26e P/E

Forward estimate

18.2x

FY27e P/E

Forward estimate

14.4x

Current P/B

Price-to-Book

1.22x

Current P/TBV

Tangible Book Value

N/A

Current EV/EBITDA

Enterprise Value

30.7x

FY26e EV/EBITDA

Forward estimate

10.6x

FY27e EV/EBITDA

Forward estimate

N/A

Dividend

ROSE pays a dividend yield of 818.97%.

Current Yield

818.97%

FY27e Net Div Yield

2.88%

FY26e Gross DPS

0.062

FY27e Gross DPS

0.089

Dividend Per Share Forecast

3. Profitability

Score: 139/280

How profitable is ROSE relative to its peers?

1/7

profitability criteria met

Metric

Sector Range

Value

Rank

–

TTM Profit Margin

15 - 30

N/A

Range: 15 - 30

–

T12 FCF Margin

N/A

-0.1%Rank 224/280

Range: N/ARank 224/280

✓

FY27e RoE

10 - 16

13.2%Rank 134/280

Range: 10 - 16Rank 134/280

✗

FY26 EPS Growth

8 - 15

-3.9%Rank 188/280

Range: 8 - 15Rank 188/280

✗

FY27e EPS Growth

6 - 12

21.3%Rank 101/280

Range: 6 - 12Rank 101/280

–

NIM

1.5 - 3.2

N/A

Range: 1.5 - 3.2

–

Expense Ratio

50 - 65

N/A

Range: 50 - 65

TTM Profit Margin

N/A

Current RoCE

-5.9%

FY27e RoE

13.2%

T12 FCF Margin

-0.1%

EPS Growth

4. Solvency

Score: 222/280

How strong is ROSE's balance sheet and financial position?

0/6

solvency criteria met

Metric

Sector Range

Value

Rank

✗

Debt/Eqt

0.5x - 1.5x

0.38xRank 121/280

Range: 0.5x - 1.5xRank 121/280

–

Interest Coverage Ratio

N/A

Rank 210Rank 210/280

Range: N/ARank 210/280

–

Net Leverage Ratio

N/A

3.18xRank 154/280

Range: N/ARank 154/280

–

Altman Z-Score (Manufacturing)

N/A

2.54Rank 191/280

Range: N/ARank 191/280

–

Z-Score (Non Manufacturing)

N/A

Rank 209Rank 209/280

Range: N/ARank 209/280

–

CapAdeq Ratio Tier1

13 - 18

N/A

Range: 13 - 18

Key Solvency Metrics

Debt/Eqt

0.38x

Net Leverage Ratio

3.18x

Interest Coverage

Rank 210

T12 FCF Margin

-0.1%

Altman Z-Score

2.54

Grey Zone

01.812.995+

5. Asset Efficiency

Score: 1/280

How efficiently does ROSE deploy its assets and intellectual capital?

0/5

asset efficiency criteria met

Metric

Sector Range

Value

Rank

–

Efficiency Ratio

50 - 70

N/A

Range: 50 - 70

–

TTM Asset Turnover Ratio

N/A

Range: N/A

–

TTM CAPEX/Sales

1 - 3

N/A

Range: 1 - 3

–

Working Capital Turnover

N/A

Range: N/A

–

R&D/Sales FY27e

N/A

Range: N/A

Overall Asset Efficiency Rank

Rank within sector peers#1/280

Best (1)Worst (280)

6. Market Trading

Score: 262/280

How liquid and actively traded is ROSE?

1/2

market trading criteria met

Metric

Sector Range

Value

Rank

✗

Intraday Sentiment (%)

40 - 75

20.0%Rank 198/280

Range: 40 - 75Rank 198/280

–

10D-Avg v/s 3M-Avg Vol

N/A

63%Rank 50/280

Range: N/ARank 50/280

✓

Avg Directional Index 30D

012 - 45

16.8Rank 187/280

Range: 012 - 45Rank 187/280

–

Parabolic SAR

N/A

322.16Rank 195/280

Range: N/ARank 195/280

–

Stock Rating Rank

N/A

Rank 100Rank 100/280

Range: N/ARank 100/280

Market Cap

£3,064,105,677

Enterprise Value

£5,364,122,356

Trading Volume

7. Technical

Score: 153/280

What do the technical indicators say about ROSE?

0/5

technical criteria met

Metric

Chart

Sector Range

Value

Rank

–

CMP v/s 52-WH

£3.95£2.94

-21.5%CMP: £3.10

N/A

-21.5%Rank 214/280

£3.95£2.94

-21.5%CMP: £3.10

Range: N/ARank 214/280

–

CMP v/s 52-WL

£3.95£2.94

+5.4%CMP: £3.10

N/A

5.4%Rank 30/280

£3.95£2.94

+5.4%CMP: £3.10

Range: N/ARank 30/280

–

RSI 14D

031.6 - Bearish100

N/A

31.6Rank 50/280

031.6 - Bearish100

Range: N/ARank 50/280

–

MA50 - MA200

£3.35-0.04£3.39

N/A

BearishRank 217/280

£3.35-0.04£3.39

Range: N/ARank 217/280

–

MACD Rank

Death Cross

MACD: -0.23

N/A

-0.23

Death Cross

MACD: -0.23

Range: N/A

RSI (14 Day)

31.6

Bearish

0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£3.35

200 SMA£3.39

SignalDeath Cross (Bearish)

MACD-0.23

Risk Metrics

Beta

N/A

3-Yr Std Dev

N/A

5-Yr Std Dev

N/A

Peer Comparison

How does ROSE compare to other Financials stocks?

Overall Rank Comparison

Factor Score Comparison

Stock	Rank	Liquidity	Valuation	Profitability	Solvency	Mkt Trading	Technical
ROSE	#67	240	224	139	222	262	153
MUT.L	#3	128	38	24	56	27	8
RTW.L	#5	116	7	9	145	69	229
BPCR.L	#7	163	34	56	9	112	76
RCP.L	#9	179	26	22	59	13	2
AGT.L	#11	108	57	55	72	90	79
TBCG.L	#14	29	55	38	257	129	18

Similar Stocks

Other top-ranked stocks in the Financials sector

View all

MUT.L

Murray Income Trust PLC

Rank #3Score: 47

RTW.L

RTW Biotech Opportunities Ltd

RIT Capital Partners PLC

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

Methodology Note

The analysis presented for Rosebank Industries PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Strategyland Research Center - strategyland.ukThis report is for informational purposes only. Not financial advice.